Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group

T. Baetz; A. Belch; S. Couban; K. Imrie; J. Yau; R. Myers; K. Ding; N. Paul; L. Shepherd; J. Iglesias; R. Meyer; Michael Crump

doi:10.1093/annonc/mdg496

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group

T. Baetz, A. Belch, S. Couban, K. Imrie, J. Yau, R. Myers, K. Ding, N. Paul, L. Shepherd, J. Iglesias, R. Meyer, Michael Crump

科研成果: 期刊稿件 › 文章 › 同行评审

146 引用（Scopus）

源语言	英语
页（从-至）	1762-1767
页数	6
期刊	Annals of Oncology
卷	14
期	12
DOI	https://doi.org/10.1093/annonc/mdg496
出版状态	已出版 - 12月 2003
已对外发布	是

!!!ASJC Scopus Subject Areas

血液学
肿瘤学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1093/annonc/mdg496

其它文件与链接

引用此

Baetz, T., Belch, A., Couban, S., Imrie, K., Yau, J., Myers, R., Ding, K., Paul, N., Shepherd, L., Iglesias, J., Meyer, R., & Crump, M. (2003). Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group. Annals of Oncology, 14(12), 1762-1767. https://doi.org/10.1093/annonc/mdg496

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group. / Baetz, T.; Belch, A.; Couban, S. 等.
在: Annals of Oncology, 卷 14, 号码 12, 12.2003, 页码 1762-1767.

科研成果: 期刊稿件 › 文章 › 同行评审

Baetz, T, Belch, A, Couban, S, Imrie, K, Yau, J, Myers, R, Ding, K, Paul, N, Shepherd, L, Iglesias, J, Meyer, R & Crump, M 2003, 'Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group', Annals of Oncology, 卷 14, 号码 12, 页码 1762-1767. https://doi.org/10.1093/annonc/mdg496

@article{6fd76e355fe14a5fafbccbaa4773cbbd,

title = "Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group",

keywords = "Gemcitabine, Hodgkin's disease, Salvage chemotherapy",

author = "T. Baetz and A. Belch and S. Couban and K. Imrie and J. Yau and R. Myers and K. Ding and N. Paul and L. Shepherd and J. Iglesias and R. Meyer and Michael Crump",

year = "2003",

month = dec,

doi = "10.1093/annonc/mdg496",

language = "English",

volume = "14",

pages = "1762--1767",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease

T2 - A phase II study by the National Cancer Institute of Canada Clinical Trials Group

AU - Baetz, T.

AU - Belch, A.

AU - Couban, S.

AU - Imrie, K.

AU - Yau, J.

AU - Myers, R.

AU - Ding, K.

AU - Paul, N.

AU - Shepherd, L.

AU - Iglesias, J.

AU - Meyer, R.

AU - Crump, Michael

PY - 2003/12

Y1 - 2003/12

KW - Gemcitabine

KW - Hodgkin's disease

KW - Salvage chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=9144246449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144246449&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg496

DO - 10.1093/annonc/mdg496

M3 - Article

C2 - 14630682

AN - SCOPUS:9144246449

SN - 0923-7534

VL - 14

SP - 1762

EP - 1767

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此